Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dora Praksch"'
Autor:
Roland Gal, Dora Praksch, Peter Kenyeres, Miklos Rabai, Kalman Toth, Robert Halmosi, Tamas Habon
Publikováno v:
Cardiovascular Therapeutics, Vol 2020 (2020)
Objectives. Several beneficial effects of resveratrol have already been published. This study evaluated the effect of resveratrol on the hemorheological parameters in patients with heart failure with reduced ejection fraction. Methods. In our double-
Externí odkaz:
https://doaj.org/article/f3fed748077b44c5babe979bf0e3e952
Autor:
Miklos Rabai, Roland Gal, Tamas Habon, Dora Praksch, Peter Kenyeres, Robert Halmosi, Kalman Toth
Publikováno v:
Cardiovascular Therapeutics
Cardiovascular Therapeutics, Vol 2020 (2020)
Cardiovascular Therapeutics, Vol 2020 (2020)
Objectives. Several beneficial effects of resveratrol have already been published. This study evaluated the effect of resveratrol on the hemorheological parameters in patients with heart failure with reduced ejection fraction. Methods. In our double-
Autor:
Dóra Endrei, Barbara Sandor, David Kovacs, Kalman Toth, Beata Csiszar, Katalin Biro, Katalin Koltai, Dora Praksch, Gabor Kesmarky, I. Juricskay
Publikováno v:
Atherosclerosis. 269:151-158
Background and aims We assumed that hand-held Doppler ultrasound (DUS) at rest was insufficient to assess the severity of peripheral artery disease (PAD). Toe pressure and transcutaneous tissue oxygen pressure were studied to prove whether these coul
Autor:
Krisztina Kovacs, Eszter Szabados, Dora Praksch, David Kovacs, Barbara Sandor, Peter Petrovics, Kalman Toth
Publikováno v:
European Review of Aging and Physical Activity
Background Data in the literature concerning the effects of physical activity on lipid and IGF-1levels are controversial in postmenopausal women. The aim of the present study was to determine the combined effects of a 12 weeks home-based walking prog
Autor:
Barbara Sandor, Dora Praksch, Károly Kalmár Nagy, M. Viola, Krisztián Tóth, Adam Varga, Péter Szakály, Ambrus Toth
Publikováno v:
Transplantation proceedings. 48(7)
Background The most common conditions leading to death after simultaneous pancreas-kidney transplantations (SPKs) are cardiovascular diseases. The aim of this study was to test the platelet aggregation inhibitor acetylsalicylic acid (ASA) resistance
Autor:
Adam, Varga, Barbara, Sandor, Karoly Kalmar, Nagy, Dora, Praksch, Katalin, Gombos, Andras, Toth, Kalman, Toth, Peter, Szakaly
Publikováno v:
In vivo (Athens, Greece). 29(2)
Leading causes of mortality and morbidity after kidney transplantation are cardiovascular diseases. One of the fundamentals of their prevention is the inhibition of platelet aggregation. Resistance to anti-platelet agents is a well-established phenom